Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Set to Surpass $1.87 Billion by 2027

The global endoscopic retrograde cholangiopancreatography market is propelled by increasing cases of gastrointestinal and chronic biliary disorders, a rise in benign tumors of the liver and pancreas, and the expanding elderly population. North America led the market in 2019 and is anticipated to maintain its dominance in the forecasted period.

In a report by Allied Market Research, the global Endoscopic Retrograde Cholangiopancreatography Market recorded $1.21 billion in 2019, with projections to reach $1.87 billion by 2027, showcasing a 5.6% CAGR from 2019 to 2027. The report provides a comprehensive examination of evolving market trends, crucial segments, prime investment opportunities, value chain dynamics, competitive landscape, and regional outlook.

Leading players of the global endoscopic retrograde cholangiopancreatography market discussed in the research include Olympus Corporation, Conmed Corporation, Hobbs Medical, Inc., TeleMed Systems, Inc., Boston Scientific Corporation, Cook Group Incorporation, Ambu, Inc., Becton, Dickinson and Company, Fujifilm Holding Corporation, and Medtronic Plc.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/4193

The global endoscopic retrograde cholangiopancreatography market is segmented extensively based on product type, application, end user, and regions.

In terms of product type, the endotherapy devices segment claimed the largest market share in 2019, comprising almost two-fifths of the total share, and is poised to maintain its leading position throughout the forecast period. Nevertheless, the endoscopes segment is projected to exhibit the highest CAGR of 6.9% from 2019 to 2027.

Regarding application, the biliary sphincterotomy segment dominated the market in 2019, contributing to over two-fifths of the global market share, and is anticipated to uphold its forefront position during the forecast period. Conversely, the pancreatic sphincterotomy segment is forecasted to demonstrate the swiftest CAGR of 7.6% from 2020 to 2027.

In terms of region, North America emerged as the dominant market player in 2019, capturing nearly two-fifths of the total market share, and is expected to maintain its lead in revenue by 2027. Conversely, Asia-Pacific is projected to exhibit the highest CAGR of 7.0% during the forecast period.